Two Sigma Investments’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Two Sigma Investments’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-352,485	Closed	-$7.51M	–	3438
2024 Q1	$7.51M	Buy	352,485 +233,552	+196%	+$2.79M	0.02%	770
2023 Q4	$1.14M	Buy	+118,933	New	+$578K	﹤0.01%	1999
2023 Q3	–	Sell	-31,154	Closed	-$145K	–	3318
2023 Q2	$145K	Sell	31,154 -13,673	-31%	-$59.1K	﹤0.01%	2701
2023 Q1	$169K	Buy	+44,827	New	+$176K	﹤0.01%	2593

Two Sigma Investments's FUSN Position: Q2 2024 in Review

Two Sigma Investments sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 352,485 shares — an estimated $7.51M sold.

Two Sigma Investments first reported a position in FUSN in Q1 2023 and held it in 4 quarters. The position peaked at $7.51M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Two Sigma Investments reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Two Sigma Investments sold 352,485 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $7.51M.
Two Sigma Investments first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2023 and held it in 4 quarters.
Two Sigma Investments's Fusion Pharmaceuticals Inc. Common Shares position peaked at $7.51M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.